Rinsho Ketsueki
Online ISSN : 1882-0824
Print ISSN : 0485-1439
ISSN-L : 0485-1439
Usefullness of Urinary Polyamine Determination in Distinguishing AML, M6 from MDS: A Case Report
Toshio ITOHYoshihumi OOMAEShirou NAKAYAMA
Author information
JOURNAL RESTRICTED ACCESS

1988 Volume 29 Issue 8 Pages 1267-1271

Details
Abstract
A 72-year-old male was admitted for the evaluation of anemia. Peripheral blood on admission showed Hb 6.2 g/dl, platelet 16×104l and WBC 5,300/μl with an almost normal differentials. Bone marrow revealed normocellularity consisted of 48.8% erythroblasts with a few megaloblastoid forms and 11.4% blastic cells. Some of blastic cells contained Auer bodies. Seventy two % of erythroblasts were ringed sideroblasts. Levels of both urinary polyamine and its fraction putrescine were extremely elevated. He was diagnosed as having RAEB-T according to the FAB classification, and blood transfusions were instituted with subsequent rapid, but transient decrease of erythroblasts and gradual increase of blastic cells in the marrow. Several months later, bone marrow showed 25.2% blastic cells, thus being compatible with the diagnosis of AML, M6 by the revised FAB classification. It is of interest in this case that urinary polyamine levels declined to the normal value as the bone marrow erythroblasts decreased.
It is well known that AML, M6 usually progresses through 3 stages in the successive order of pure erythremic, erythroleukemic and leukemic picture. Therefore, pure erythremic stage might be difficult in distinguishing from MDS. In view of the reports that urinary polyamine levels are high in neoplasia including acute leukemia but not in MDS, it is able to infer from our case that bone marrow erythroblasts were possessed of possibly neoplastic disturbance already at the initial stage. Determination of urinary polyamine may be useful in distinguishing AML, M6 from MDS.
Content from these authors
© 1988 The Japanese Society of Clinical Hematology
Previous article Next article
feedback
Top